Tessera
Folgen

Kirstin Oliveira Roster

@kroster.bsky.social

Infectious disease modeling and forecasting, global health, surveillance of drug resistance. Postdoc @ Harvard School of Public Health

12 Posts120 Follower106 Folgt
CCDD@ccdd-hsph.bsky.social · 7mo ago

New publication! Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study featuring authors: @mckline98.bsky.social, @kroster.bsky.social, @dhelekal.bsky.social, @rumpl-er.bsky.social, and @yhgrad.bsky.social. Read it here at bit.ly/3Z1Zplh

Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study

Immediately introducing 2 new antibiotics to treat gonorrhea alongside 1 currently used therapy is more effective at minimizing drug resistance than holdin

bit.ly

CCDD@ccdd-hsph.bsky.social · 8mo ago

U.S. gonorrhea rates fell in 2022 and 2023 after nearly a decade of increases—new paper by @kroster.bsky.social and @yhgrad.bsky.social maps out possible drivers, current evidence, and the data needed to understand what is causing the decline. Read more at bit.ly/4aWmc9i

Why are gonorrhea case rates declining in the US? A research agenda - PubMed

After nearly a decade of rising gonorrhea rates, the United States CDC reported a decline in infection rates for two years in a row in 2022 and 2023, especially among young adults. While this warrants cautious optimism that control measures have been successful, the reasons for the decline are unkno …

bit.ly

Madeleine Kline@mckline98.bsky.social · last yr.

⚠️ New preprint ⚠️: Two new antibiotics are likely coming for gonorrhea 💊. How should we deploy them in the US to minimize drug resistance? @kroster.bsky.social @dhelekal.bsky.social Eva Rumpler @yhgrad.bsky.social [1/10] www.medrxiv.org/content/10.1...

Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study

Introduction Drug resistance in Neisseria gonorrhoeae is an urgent public health threat. The anticipated approval of two new antimicrobials for gonorrhea prompts the need for evidence-based rollout st...

medrxiv.org

Kirstin Oliveira Roster@kroster.bsky.social · last yr.

New preprint. After years of increases, gonorrhea diagnosis rates dropped in the US in 2022 and 2023. While the news is promising, understanding WHY is key to sustaining progress. dash.harvard.edu/handle/1/427...

Why are gonorrhea diagnoses declining in the US?

After a decade of rising cases, the US CDC reported a decline in the rate of gonorrhea diagnoses for two years in a row in 2022 and 2023, especially among young adults. Primary and secondary syphilis ...

dash.harvard.edu

Yonatan Grad@yhgrad.bsky.social · 2y ago

Now published in AJE: academic.oup.com/aje/advance-...

Estimating the undetected burden and the likelihood of strain persistence of drug-resistant Neisseria gonorrhoeae

Abstract. Neisseria gonorrhoeae has developed resistance to all antibiotics recommended for treatment and reports of reduced susceptibility to ceftriaxone,

academic.oup.com

Yonatan Grad@yhgrad.bsky.social · 2y ago

New work from the lab led by @kroster.bsky.social! With the recent detection in Massachusetts of cases of gonorrhea resistant or non-susceptible to all approved antibiotics, we sought to understand how many cases there were likely to be and when we could be confident they were no longer spreading.

Kirstin Oliveira Roster@kroster.bsky.social · 2y ago

New preprint: Drug resistant gonorrhea is a big public health problem. Resistance to ceftriaxone, the last approved antibiotic, is spreading globally. When we first detect one of these very resistant isolates, how many undetected cases are there likely to be? www.medrxiv.org/content/10.1...

Estimating the undetected burden of infections and the likelihood of strain persistence of drug-resistant Neisseria gonorrhoeae

Antimicrobial resistance (AMR) is a serious public health threat. Neisseria gonorrhoeae has developed resistance to all antibiotics recommended for treatment and reports of reduced susceptibility to c...

medrxiv.org